Nu har den kommit !
Analysen tar sin ansats i det som kännetecknar HoloMonitor, live cell imaging, så den känns än mer angelägen och betydelsefull för PHI och den nära framtid bolaget står inför. Innan man läser analysen ska man ha några HoloMonitor nyckelfaktorer i åtanke.Den nu färdiga Holo/Fluo-kombon, instrumentets särställning inom stamcellsforskning och som kommande nav inom den Regenerativa Medicinen. Man kan även addera instrumentets betydelse för "personalized medicine" som anges i texten.
Men till analysen daterad 6 Juni 2023 :
Deep Learning & AI Igniting Live Cell Imaging Market Expansion the Market to Worth $3.54 Billion by 2028 – Arizton
The global live-cell imaging market growth is primarily driven by the increasing prevalence of cancer and infectious diseases, which require innovative therapies. Additionally, the demand for cell biology studies and the growing awareness of stem cell therapy contributes to live-cell imaging technologies’ adoption.
Researchers from pharmaceutical and biotech companies, academic institutions, and research centers heavily rely on fluorescence microscopy techniques, resulting in a high demand for live-cell imaging systems. Furthermore, integrating artificial intelligence (AI) and machine learning in live-cell imaging will drive the market’s growth in the coming years.
Overall, the expanding global live-cell imaging market signifies the importance of these technologies in various fields. With advancements in AI and machine learning and the rising demand for novel therapies and cell biology research, live-cell imaging is poised to play a crucial role in driving advancements in healthcare and life sciences.
Geographical Analysis
The global live cell imaging market is poised for substantial growth, with North America leading. This growth is primarily driven by increased healthcare spending and funding for research and development in live cell-driven drug discovery, development, and personalized medicine.
The Asia-Pacific (APAC) region is expected to witness the fastest growth in the global live cell imaging market. Key factors contributing to this growth include a continual rise in the prevalence of cancers and infectious diseases, increasing demand for stem cell research studies, rising research and development expenditures, the growing utility of biomarkers for diagnostic purposes, heightened awareness of cell and gene therapies, the need for precision medicine, and advancements in drug discovery, cell biology, and development.
The expansion of the live cell imaging market indicates the increasing importance of these systems in various sectors. They play a crucial role in diagnostics, drug discovery and development, and precision medicine. As research and technological advancements progress, live cell imaging systems are expected to become even more essential tools in healthcare and life sciences.
Market Trends & Opportunities
Deep Learning & Artificial Intelligence
The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently, AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.
Increase in Funding for Cell & Gene Therapy
The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers. Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.
Advancements & Newer Imaging Techniques
Live cell imaging arises from scientific interest and improvements in imaging and labeling technology. Combining various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.
Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.
Key Vendors
- Danaher
- Agilent Technologies
- PerkinElmer
- Merck KGaA
- ZEISS
- Thermo Fisher Scientific
Och scrollar man neråt bland dessa identifierade nyckelaktörer hittar man..."tadaa" ...
- Phase Holographic Imaging PHI AB
Tack för ett intressant inlägg! Vi ligger verkligen helt rätt i tiden. Hoppas att den sista pusselbiten kan falla på plats snart, sen kan budkriget om PHI börja:)
SvaraRadera